-
Loading metrics
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
- William Pao,
- Vincent A Miller,
- Katerina A Politi,
- Gregory J Riely,
- Romel Somwar,
- Maureen F Zakowski,
- Mark G Kris,
- Harold Varmus
x
- Published: February 22, 2005
- https://doi.org/10.1371/journal.pmed.0020073